Self‐management of immunomodulatory drug treatment in multiple myeloma patients-Reference-Cited by-同舟云学术

Self‐management of immunomodulatory drug treatment in multiple myeloma patients

Published:2020-11-06 Issue:1 Volume:30 Page:
ISSN:0961-5423
Container-title:European Journal of Cancer Care
language:en
Short-container-title:Eur J Cancer Care

Author:

Cransac Amélie¹²^ORCID,Aho Serge³,Cosme Edouard¹,Chretien Marie‐Lorraine⁴⁵,Favennec Camille⁴,Schreder Laure⁶,Boutet Mérédith¹,Gueneau Pauline¹,Giroud Maurice²⁷,Caillot Denis⁴,Boulin Mathieu¹⁸

Affiliation:

1. Department of Pharmacy Dijon University Hospital Dijon France

2. LNC‐UMR1231 University of Burgundy and Franche Comté Dijon France

3. Hospital Epidemiology and Infection Control Department Dijon University Hospital Dijon France

4. Department of Clinical Hematology Dijon University Hospital Dijon France

5. SAPHIIR‐UMR 1231 University of Burgundy and Franche Comté Dijon France

6. Oncology Coordination Center Dijon University Hospital Dijon France

7. Department of Neurology Dijon University Hospital Dijon France

8. EPICAD LNC‐UMR1231 University of Burgundy and Franche Comté Dijon France

Publisher

Wiley

Subject

Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ecc.13356

Reference29 articles.

1. Analysis of Ordinal Categorical Data

2. The Effect of Self-Management Education by the Teach-Back Method on Uncertainty of Patients with Breast Cancer: a Quasi-Experimental Study

3. Do patients on oral chemotherapy have sufficient knowledge for optimal adherence? A mixed methods study

4. Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment

5. Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial